Clinical Trials Directory

Trials / Sponsors / Wuhan Createrna Science and Technology Co., Ltd

Wuhan Createrna Science and Technology Co., Ltd

Industry · 12 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingStudy of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 22025-12-01
Not Yet RecruitingStudy to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (
IgA Nephropathy (IgAN)
Phase 22024-12-31
Not Yet RecruitingQR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension
Essential Hypertension
Phase 32024-12-30
RecruitingLong-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 2 / Phase 32024-11-30
RecruitingStudy of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive
Paroxysmal Nocturnal Haemoglobinuria (PNH)
Phase 32024-08-30
RecruitingStudy of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
Paroxysmal Nocturnal Hemoglobinuria
Phase 32024-08-30
Not Yet RecruitingTo Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects
Paroxysmal Nocturnal Hemoglobinuria
Phase 12024-08-10
CompletedA Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal Nocturnal Hemoglobinuria
Phase 22023-07-06
CompletedQR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ Study
Cough
Phase 22023-06-21
CompletedA Study of Multiple Ascending Doses MY008211A in Healthy Adults
Paroxysmal Nocturnal Hemoglobinuria
Phase 12023-01-10
CompletedEffect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects
Paroxysmal Nocturnal Hemoglobinuria
Phase 12022-09-26
CompletedA Study of Single-dose MY008211A in Healthy Adults
Paroxysmal Nocturnal Hemoglobinuria
Phase 12022-05-27